Alcendor Donald J, Matthews-Juarez Patricia, Smoot Duane, Hildreth James E K, Lamar Kimberly, Tabatabai Mohammad, Wilus Derek, Juarez Paul D
Department of Microbiology, Immunology and Physiology, Center for AIDS Health Disparities Research, School of Medicine, Meharry Medical College, 1005 D.B. Todd Jr. Blvd., Nashville, TN 37208, USA.
Center for AIDS Health Disparities Research, Department of Microbiology, Immunology, and Physiology, School of Medicine, Meharry Medical College, 1005 D.B. Todd Jr. Blvd., Hubbard Hospital, 5th Floor, Rm. 5025, Nashville, TN 37208, USA.
Vaccines (Basel). 2022 May 11;10(5):755. doi: 10.3390/vaccines10050755.
The incidence of COVID-19 breakthrough infections-an infection that occurs after you have been vaccinated-has increased in frequency since the Delta and now Omicron variants of the SARS-CoV-2 coronavirus have become the dominant strains transmitted in the United States (US). Evidence suggests that individuals with breakthrough infections, though rare and expected, may readily transmit COVID-19 to unvaccinated populations, posing a continuing threat to the unvaccinated. Here, we examine factors contributing to breakthrough infections including a poor immune response to the vaccines due to the fact of advanced age and underlying comorbidities, the natural waning of immune protection from the vaccines over time, and viral variants that escape existing immune protection from the vaccines. The rise in breakthrough infections in the US and how they contribute to new infections, specifically among the unvaccinated and individuals with compromised immune systems, will create the need for additional booster vaccinations or development of modified vaccines that directly target current variants circulating among the general population. The need to expedite vaccination among the more than 49.8 million unvaccinated eligible people in the US is critical.
自新冠病毒(SARS-CoV-2)的德尔塔毒株,以及现在的奥密克戎毒株成为美国主要传播毒株以来,新冠病毒突破性感染(即在接种疫苗后发生的感染)的发生率不断上升。有证据表明,突破性感染的个体虽然罕见但也在意料之中,他们可能会轻易地将新冠病毒传播给未接种疫苗的人群,对未接种疫苗者构成持续威胁。在此,我们研究了导致突破性感染的因素,包括由于高龄和潜在合并症对疫苗免疫反应不佳、疫苗免疫保护随时间自然减弱,以及逃避现有疫苗免疫保护的病毒变体。美国突破性感染的增加及其如何导致新的感染,特别是在未接种疫苗者和免疫系统受损个体中的感染,将产生对额外加强疫苗接种或开发直接针对普通人群中当前流行变体的改良疫苗的需求。加快美国4980多万符合条件但未接种疫苗人群的疫苗接种至关重要。